MedPath

Effect of Stinging Nettle (Urtica dioica L.) extract in patients with Benign Prostate Hyperplasia

Phase 2
Completed
Conditions
Benign Prostate Hyperplasia.
Enlarged prostate
Registration Number
IRCT20170430033730N4
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
60
Inclusion Criteria

Patients with benign prostatic hyperplasia

Exclusion Criteria

Patients who use anticoagulant
Diabetic patients
Patients with hypo and/or hyperthyroidism

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
International Prostate Symptom Score (I-PSS). Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: Standard questionnaire.;Insulin. Timepoint: At the beginning of the study and 12 weeks after the intervention. Method of measurement: calculation based on standard formula.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath